Quorum Review IRB Establishes an East Coast Ethics Board Focused on Oncology - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Quorum Review IRB Establishes an East Coast Ethics Board Focused on Oncology

Source: Company News Release
Quorum Review IRB is introducing a new ethics board located in Cambridge, Massachusetts. This panel includes members from academia with significant expertise in oncology research. The Cambridge Board will begin reviewing studies on October 4, 2011.  Quorum will continue to hold eight board meetings each week.      

Oncology is a complex, fast-moving, and innovative area of clinical research. With this panel, researchers can benefit from IRB members with years of experience in oncology treatment and research. Quorum’s broad range of therapeutic expertise will also be supported as members are affiliated with a range of institutions, including Harvard Medical School, Dana Farber, Tufts, and Boston University.

The Cambridge Board will meet weekly. Researchers may also submit oncology studies to the next available Board meeting, as Quorum always includes oncology expertise on a panel when a cancer study is presented for review.   

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Company News Release,
Click here